SUN bioscience creates advanced cell culture platforms.
Business Model:
Revenue: $0
Employees: 1-10
Address:
City: Lausanne
State: Vaud
Zip:
Country: Switzerland
SUN bioscience is enabling personalized medicine through patient-specific organoids cultured on SUN’s proprietary high-throughput 3D microwell platform. Organoids are self-organizing 3D miniature tissues with organ-mimicking functions that are grown from stem cells. They are powerful human in vitro models for assessing pharmaceutical efficacy and toxicity early on in drug development. The SUN technology is solving the problems that organoid culture today cannot be scaled and automated. This will introduce a new area of drug discovery where we can understand drug performance outside of an animal or a human being.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 1/2016 | Non Equity Assistance | 1 | - |
MassChallenge MassChallenge |
5/2021 | Debt Financing | 1 | $553.1k |
Foundation for Technological Innovation (FIT) Foundation for Technological Innovation (FIT) |
6/2015 | Grant | 1 | $100k |
FOUNDER.org FOUNDER.org |
1/2021 | Seed Round | 2 | - |
Acequia Capital (AceCap) Possible Ventures Acequia Capital (AceCap) Possible Ventures |
6/2017 | Debt Financing | 1 | $102.6k |
Foundation for Technological Innovation (FIT) Foundation for Technological Innovation (FIT) |
1/2021 | Seed Round | 2 | - |
Acequia Capital (AceCap) Possible Ventures Acequia Capital (AceCap) Possible Ventures |
1/2016 | Non Equity Assistance | 1 | - |
MassChallenge MassChallenge |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|